[1]
Sebak, A.A. 2018. LIMITATIONS OF PEGYLATED NANOCARRIERS: UNFAVOURABLE PHYSICOCHEMICAL PROPERTIES, BIODISTRIBUTION PATTERNS AND CELLULAR AND SUBCELLULAR FATES. International Journal of Applied Pharmaceutics. 10, 5 (Sep. 2018), 6–12. DOI:https://doi.org/10.22159/ijap.2018v10i5.27568.